YU49221B - Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova - Google Patents

Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova

Info

Publication number
YU49221B
YU49221B YU21695A YU21695A YU49221B YU 49221 B YU49221 B YU 49221B YU 21695 A YU21695 A YU 21695A YU 21695 A YU21695 A YU 21695A YU 49221 B YU49221 B YU 49221B
Authority
YU
Yugoslavia
Prior art keywords
carbon atoms
hydrogen atom
heteroatoms
medicines
procedure
Prior art date
Application number
YU21695A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU21695A (sh
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Roussel-Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel-Uclaf filed Critical Roussel-Uclaf
Publication of YU21695A publication Critical patent/YU21695A/sh
Publication of YU49221B publication Critical patent/YU49221B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
YU21695A 1994-04-08 1995-04-05 Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova YU49221B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
YU21695A YU21695A (sh) 1997-12-05
YU49221B true YU49221B (sh) 2004-11-25

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
YU21695A YU49221B (sh) 1994-04-08 1995-04-05 Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova

Country Status (49)

Country Link
US (2) US5656607A (enExample)
EP (1) EP0676409B1 (enExample)
JP (1) JP3000023B2 (enExample)
KR (1) KR100317148B1 (enExample)
CN (1) CN1059445C (enExample)
AP (1) AP587A (enExample)
AT (1) ATE234853T1 (enExample)
AU (1) AU684939B2 (enExample)
BG (1) BG61916B1 (enExample)
BR (1) BR9506147A (enExample)
CA (1) CA2164638C (enExample)
CO (1) CO4370097A1 (enExample)
CZ (1) CZ296005B6 (enExample)
DE (1) DE69529934T2 (enExample)
DK (1) DK0676409T3 (enExample)
DZ (1) DZ1869A1 (enExample)
EE (1) EE04498B1 (enExample)
ES (1) ES2189820T3 (enExample)
FI (1) FI111264B (enExample)
FR (1) FR2718450B1 (enExample)
GB (1) GB2288174A (enExample)
GE (1) GEP19991836B (enExample)
HR (1) HRP950217B1 (enExample)
HU (1) HU215396B (enExample)
IL (1) IL112954A (enExample)
IS (1) IS1865B (enExample)
JO (1) JO1850B1 (enExample)
LV (1) LV11182B (enExample)
MA (1) MA23501A1 (enExample)
MD (1) MD663G2 (enExample)
MY (1) MY114672A (enExample)
NO (1) NO308361B1 (enExample)
NZ (1) NZ284498A (enExample)
OA (1) OA10200A (enExample)
PE (1) PE2896A1 (enExample)
PL (1) PL180837B1 (enExample)
PT (1) PT676409E (enExample)
RO (1) RO115634B1 (enExample)
RU (1) RU2141965C1 (enExample)
SA (1) SA97170757A (enExample)
SI (1) SI0676409T1 (enExample)
SK (1) SK284079B6 (enExample)
SV (1) SV1995000018A (enExample)
TN (1) TNSN95026A1 (enExample)
TW (1) TW316908B (enExample)
UA (1) UA44705C2 (enExample)
WO (1) WO1995027720A1 (enExample)
YU (1) YU49221B (enExample)
ZA (1) ZA952059B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
DE69723848T2 (de) * 1996-05-07 2004-07-01 Abbott Laboratories, Abbott Park 3-descladinose-2,3-anhydroerythromycin-derivate
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
IL128681A0 (en) * 1996-09-04 2000-01-31 Abbott Lab 6-O substituted ketolides having antibacterial activity
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO1998042720A1 (fr) * 1997-03-24 1998-10-01 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
BR9810021A (pt) * 1997-06-11 2000-09-19 Pfizer Prod Inc Derivados 9-oxima-eritromicina
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
ES2243066T3 (es) 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TR200102129T2 (tr) 1998-12-10 2002-01-21 Pfizer Products Inc. Karbamat ve karbazat ketolid antibiyotikleri.
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
WO2000062783A2 (en) 1999-04-16 2000-10-26 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EP1180110A1 (en) * 1999-05-24 2002-02-20 Pfizer Products Inc. 13-methyl-erythromycin derivatives
CA2451391A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
MXPA04012978A (es) 2002-07-01 2005-09-12 Arkion Life Sciences Llc D B A Proceso y material para la produccion de glucosamina y n-acetilglucosamina.
EP2772254A3 (en) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Novel Antibacterial Agents
US7332476B2 (en) * 2003-04-25 2008-02-19 Novartis Ag Pyridyl substituted ketolide antibiotics
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
CA2703475A1 (en) * 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
AU2009308182B2 (en) 2008-10-24 2016-05-19 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
WO2011032052A1 (en) 2009-09-10 2011-03-17 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
WO2011119604A1 (en) 2010-03-22 2011-09-29 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
KR20160020403A (ko) 2013-03-15 2016-02-23 셈프라 파마슈티컬스, 인크. 매크로라이드 항세균제들을 제조하기 위한 수렴 프로세스들
WO2014165792A2 (en) 2013-04-04 2014-10-09 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
HK1242920A1 (zh) 2014-10-08 2018-07-06 哈佛大学的校长及成员们 14-元酮内酯及其制备和使用方法
CN107530365A (zh) 2015-03-25 2018-01-02 哈佛大学的校长及成员们 具有修饰的脱氧糖胺糖的大环内酯及其用途
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
IS1865B (is) 2003-05-02
LV11182A (lv) 1996-04-20
AU684939B2 (en) 1998-01-08
KR100317148B1 (ko) 2002-06-22
US5760233A (en) 1998-06-02
TW316908B (enExample) 1997-10-01
HRP950217A2 (en) 1997-08-31
LV11182B (en) 1997-04-20
EE04498B1 (et) 2005-06-15
EP0676409A1 (fr) 1995-10-11
HRP950217B1 (en) 2004-06-30
IS4309A (is) 1995-11-17
ZA952059B (en) 1996-03-13
MD663G2 (ro) 1997-07-31
GB9506856D0 (en) 1995-05-24
FI955913A7 (fi) 1995-12-08
AP9500743A0 (en) 1995-07-31
SV1995000018A (es) 1997-10-24
DE69529934T2 (de) 2003-09-04
NO308361B1 (no) 2000-09-04
HU9503505D0 (en) 1996-02-28
JP3000023B2 (ja) 2000-01-17
PE2896A1 (es) 1996-02-12
US5656607A (en) 1997-08-12
GEP19991836B (en) 1999-11-05
PT676409E (pt) 2003-08-29
NO954942L (no) 1996-02-07
CN1059445C (zh) 2000-12-13
HU215396B (hu) 1998-12-28
BR9506147A (pt) 1996-04-16
CZ296005B6 (cs) 2005-12-14
FR2718450B1 (fr) 1997-01-10
AU2310795A (en) 1995-10-30
SK284079B6 (sk) 2004-09-08
OA10200A (fr) 1996-12-18
PL311871A1 (en) 1996-03-18
BG61916B1 (bg) 1998-09-30
SK154695A3 (en) 1996-10-02
CA2164638A1 (fr) 1995-10-19
SI0676409T1 (en) 2003-06-30
CZ322395A3 (en) 1996-08-14
NO954942D0 (no) 1995-12-06
MA23501A1 (fr) 1995-12-31
MD663F1 (ro) 1997-01-31
DZ1869A1 (fr) 2002-02-17
DE69529934D1 (de) 2003-04-24
UA44705C2 (uk) 2002-03-15
DK0676409T3 (da) 2003-06-23
FI955913A0 (fi) 1995-12-08
RO115634B1 (ro) 2000-04-28
IL112954A0 (en) 1995-06-29
HUT73772A (en) 1996-09-30
ES2189820T3 (es) 2003-07-16
FI111264B (fi) 2003-06-30
CN1126997A (zh) 1996-07-17
SA97170757A (ar) 2005-12-03
WO1995027720A1 (fr) 1995-10-19
IL112954A (en) 2000-07-16
NZ284498A (en) 1997-07-27
GB2288174A (en) 1995-10-11
YU21695A (sh) 1997-12-05
RU2141965C1 (ru) 1999-11-27
MY114672A (en) 2002-12-31
CA2164638C (fr) 2003-12-30
BG100150A (bg) 1996-06-28
TNSN95026A1 (fr) 1996-02-06
CO4370097A1 (es) 1996-10-07
PL180837B1 (pl) 2001-04-30
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
JPH07278177A (ja) 1995-10-24
AP587A (en) 1997-04-29
ATE234853T1 (de) 2003-04-15
FR2718450A1 (fr) 1995-10-13
EE9500080A (et) 1996-12-16

Similar Documents

Publication Publication Date Title
YU49221B (sh) Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova
NZ505968A (en) Sulfonylamino derivatives which inhibit matrix- degrading metallproteinases
KR890011601A (ko) (사이클로알킬아미노)메틸렌비스(포스폰산)및 활성성분으로서 이를 함유한 의약
CZ15795A3 (en) Derivatives of hydroxamic acid, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
DK0763049T3 (da) Nukleosid-monophosphatderivater, fremgangsmåde til fremstilling heraf og anvendelse heraf som immunundertrykkende lægemidler
UA48937C2 (uk) Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
IE872588L (en) Compounds
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
PH21177A (en) 1,6-naphthyridine derivatives, pharmaceutical compositions containing them and method of use
BG105923A (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
ATE215934T1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
FR2616663B1 (fr) Nouveaux tripeptides a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE34739T1 (de) Neue 2-pyridin-thiol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
AR002259A1 (es) Derivados de 1-oxo-2-(fenilsulfonilamino)pentilpiperidina, su preparacion, compuestos intermedios y composicion que contiene a dichos derivados.
PT76861A (fr) Procede de preparation de nouveaux derives d'oxazinobenzothiazine-6,6-dioxide et de compositions pharmaceutiques les contenant
HRP20000733B1 (hr) NOVI DERIVATI OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] [1,2]DIAZEPIN-1-KARBOKSILNE KISELINE, POSTUPAK NJIHOVOG DOBIVANJA I UPOTREBA U DOBIVANJU TERAPEUTSKI AKTIVNIH SPOJEVA
DE3578608D1 (de) Substituierte azabicycloheptane, ihre verwendung, pharmazeutische praeparate, welche diese verbindungen enthalten, und verfahren zur herstellung dieser verbindungen.
YU48094B (sh) Derivati fenoksietilamina i postupak za njihovo dobijanje
KR880013562A (ko) 7-티아프로스타글란딘e₁ 또는 그의 유도체를 함유하는 당뇨병치료 조성물
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
EP0035360A3 (en) 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives, the production thereof and compositions containing them
DE3166727D1 (en) Derivatives of 2-thiazolyl-oxamic acid substituted in position 4 by a thienyl or furyl radical, their preparation and use as pharmaceutical preparations
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.